APC: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
APC (Adenomatous Polyposis Coli) | |||
The '''[[Adenomatous Polyposis Coli (APC)]]''' gene is a crucial tumor suppressor gene that plays a significant role in the regulation of cell growth and apoptosis. Mutations in the APC gene are associated with familial adenomatous polyposis (FAP), a hereditary condition that greatly increases the risk of developing colorectal cancer. | |||
== | ==Function== | ||
The APC gene encodes a protein that is involved in several cellular processes, including cell cycle regulation, cell migration, and chromosomal stability. One of its primary functions is to regulate the Wnt signaling pathway, which is critical for controlling cell proliferation and differentiation. | |||
In the Wnt signaling pathway, the APC protein forms a complex with other proteins such as [[Axin]] and [[GSK-3β]] to promote the degradation of β-catenin. When the APC gene is mutated, this degradation process is disrupted, leading to the accumulation of β-catenin in the nucleus and the activation of genes that promote cell division and tumor growth. | |||
== | ==Clinical Significance== | ||
Mutations in the APC gene are most commonly associated with familial adenomatous polyposis (FAP), an autosomal dominant disorder characterized by the development of hundreds to thousands of adenomatous polyps in the colon and rectum. If left untreated, these polyps have a high likelihood of progressing to colorectal cancer. | |||
APC mutations are also found in sporadic colorectal cancers, where they contribute to the early stages of tumor development. The loss of APC function is considered a key event in the adenoma-carcinoma sequence, a model describing the progression from benign adenomas to malignant carcinomas in the colon. | |||
== | ==Diagnosis and Management== | ||
Genetic testing for APC mutations can confirm a diagnosis of FAP in individuals with a family history of the condition or in those who present with multiple colorectal polyps. Early diagnosis allows for regular surveillance and management strategies, such as prophylactic colectomy, to reduce the risk of cancer development. | |||
== | ==Research and Future Directions== | ||
Ongoing research is focused on understanding the full spectrum of APC mutations and their effects on protein function. There is also interest in developing targeted therapies that can restore APC function or counteract the effects of its loss. Such therapies could provide new treatment options for patients with APC-related cancers. | |||
== | ==Also see== | ||
* [[Familial adenomatous polyposis]] | |||
* [[Colorectal cancer]] | |||
* [[Wnt signaling pathway]] | |||
* [[Tumor suppressor gene]] | |||
{{Genetics}} | |||
{{Colorectal cancer}} | |||
[[Category:Genetics]] | |||
[[Category:Oncology]] | |||
[[Category:Tumor suppressor genes]] | |||
Latest revision as of 22:23, 15 December 2024
APC (Adenomatous Polyposis Coli)
The Adenomatous Polyposis Coli (APC) gene is a crucial tumor suppressor gene that plays a significant role in the regulation of cell growth and apoptosis. Mutations in the APC gene are associated with familial adenomatous polyposis (FAP), a hereditary condition that greatly increases the risk of developing colorectal cancer.
Function[edit]
The APC gene encodes a protein that is involved in several cellular processes, including cell cycle regulation, cell migration, and chromosomal stability. One of its primary functions is to regulate the Wnt signaling pathway, which is critical for controlling cell proliferation and differentiation.
In the Wnt signaling pathway, the APC protein forms a complex with other proteins such as Axin and GSK-3β to promote the degradation of β-catenin. When the APC gene is mutated, this degradation process is disrupted, leading to the accumulation of β-catenin in the nucleus and the activation of genes that promote cell division and tumor growth.
Clinical Significance[edit]
Mutations in the APC gene are most commonly associated with familial adenomatous polyposis (FAP), an autosomal dominant disorder characterized by the development of hundreds to thousands of adenomatous polyps in the colon and rectum. If left untreated, these polyps have a high likelihood of progressing to colorectal cancer.
APC mutations are also found in sporadic colorectal cancers, where they contribute to the early stages of tumor development. The loss of APC function is considered a key event in the adenoma-carcinoma sequence, a model describing the progression from benign adenomas to malignant carcinomas in the colon.
Diagnosis and Management[edit]
Genetic testing for APC mutations can confirm a diagnosis of FAP in individuals with a family history of the condition or in those who present with multiple colorectal polyps. Early diagnosis allows for regular surveillance and management strategies, such as prophylactic colectomy, to reduce the risk of cancer development.
Research and Future Directions[edit]
Ongoing research is focused on understanding the full spectrum of APC mutations and their effects on protein function. There is also interest in developing targeted therapies that can restore APC function or counteract the effects of its loss. Such therapies could provide new treatment options for patients with APC-related cancers.
Also see[edit]
| Genetics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
* Category
|